A regular cholesterol test is useful, but it doesn't always capture the complete picture of heart disease risk.

Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, is making progress in gaining broad access to Medicare reimbursement for its Epi+Gen CHD™ and ...

For the first time, researchers have developed tests that could improve treatment for heart failure patients by diagnosing the condition with greater accuracy, as well as by detecting the onset of ...

The heart's ability to use oxygen efficiently is a critical indicator of its health, but tests to measure this function have drawbacks that can limit their use. A new Cedars-Sinai Health Sciences ...

A panel of experts recommends limited use of a test that measures inflammation in the blood, a newly discovered cause and predictor of heart disease. The test, known as C-reactive protein, or CRP, ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a (Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP ...

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 clinical labs and more than 300 doctors to expand the reach of its precision ...